Comparison of Serum Uric Acid, Iron and Total Iron Binding Capacity (TIBC) Levels in Pre-eclamptic and Normal Pregnant Women
,
Abstract
Objective: The objective of our study was to compare uric acid, iron and TIBC levels in normal and preeclamptic pregnant women and determine their relations with maternal and fetal complications.
Materials and methods: A case control study was conducted in 200 normal and preeclamptic pregnant women. At 32-40 weeks of pregnancy (third trimester) a blood test was taken in order to measure the uric acid, iron and TIBC and their relation with maternal and fetal complications.
Results: Uric acid level showed significant difference (4.58 ± 0.73, 4.87 ± 0.58, p=0.002) between two groups of pre-eclamptic and normal women. The iron and TIBC level had no significant difference in either group. The uric acid level and iron had significant differences between two groups with and without maternal complication, respectively (4.69 ± 0.66, 5.05 ± 0.59, p<0.05) (387.42 ± 82, 405.24 ± 57, p<0.05). There was not any difference in three parameters between groups with and without fetal complication. The BMI was significantly higher in preeclamptic group and has positive relation with uric acid level. If we consider 29 as BMI cut-off point; it will be associated with 73% sensitivity and 67% specificity in preeclampsia determination. Using 4.55 as uric acid cut-off point, the sensitivity is 76% and specificity is 49%.
Conclusion: Although the higher level of uric acid, higher BMI scale and positive roll-over test are associated with preeclampsia, but they are not very strong predictors as single test.
Roberts JM, Cooper DW. Pathogenesis and genetics of preeclampsia. Lancet 2001; 357: 53–6.
Cunningham FG, Leveno KJ, Bloom SL, Hauth JC,. Rouse DJ, Spong CY. Pregnancy Hypertension. Williams Obstetrics 23 rd edition. USA McGraw–Hill; 2010: 706–56.
Habli M, Sibai BM. Hypertensive disorders of pregnancy. In: Gibbs RS, Karlan BY, Haney AF, Nygaard IE. Danforth,s Obstetrics & Gynecology; Lippincott Williams & Wilkins. 10th edition; 2008: 257–76.
Williams KP, Galerneau F. The role of serum uric acid as a prognostic indicator of the severity of maternal and fetal complications in hypertensive pregnancies. J Obstet Gynaecol Can 2002; 24: 628–32.
Thangaratinam S, Ismail K, Sharp S, Coomarasamy A, Khan K. Accuracy of serum uric acid in predicting complications of preeclampcia: Tests in Prediction of Pre–eclampsia Severity review group. BJOG 2006; 113: 369–78.
Koopmans CM, van Pampus MG, Groen H, Aarnoudse JG, van den Berg PP, Mol BW. Accuracy of serum uric acid as a predictive test for maternal complications in pre–eclampsia: bivariate meta–analysis and decision analysis. Eur J Obstet Gynecol Reprod Biol 2009; 146: 8–14.
Carter J, Child A. Serum uric acid levels in normal pregnancy. Aust NZ J Obstet Gynaecol 1989; 29: 313– 4.
Chappel LC, Seed PT, Briley A, Kelly FJ, Hunt BJ Charnock–Jones DS, et al. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 2002; 187: 127–36.
Edelstam G, Lowbeer C, Kral G, Gustafsson SA, Venge P. new reference values for routine blood samples and human neutrophilic lipocalcin during third–trimester pregnancy. Scand J Clin Lab Invest 2001; 61: 583–92.
Sibai BM. Hypertension in pregnancy In:Gabbe SG, Niebyl JR, Simpson JL. Obstetrics normal and problem pregnancies; Churchill Livingtone. 5th edition .2007, 863–912.
Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41: 1183–90.
Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1972; 1: 177–91.
Balla J, Jacob HS, Balla G, Nath K, Eaton JW, Vercelloti GM. Endothelial–cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci USA 1993; 90: 9285–9.
Hubel CA, Roberts JM, Taylor RN, Musci TJ, Rogers JM, McLaughlin MK. Lipid peroxidation in preeclampsia: new perspectives on preeclampsia. Am J Obstet Gynecol 1989; 161: 1025–34.
Hubel CA, Kozlov AV, Kagan EV, Evans RW, Davidge ST, McLaughlin MK, et al. Decreased transferring and increased transferrin saturation in sera of women with preeclampsia: Implications for oxidative stress. Am J Obstet Gynecol 1996; 175: 692–700.
Rayman MP, Barlis J, Evans RW, Redman CW, King LJ. Abnormal iron parameters in the pregnancy syndrome preeclampsia. Am J Obstet Gynecol 2002; 187: 412–8.
Samuels P, Main EK, Mennuti MT, Gabbe SG. The origin of increased serum iron in pregnancy–induced hypertension. Am J Obstet Gynecol 1987; 157: 721–5.
Rajasingam D, Seed PT, Briley AL, Shennan AH, Poston L. A prospective study of pregnancy outcome and biomarkers of oxidative stress in nulliparous obese woman. Am J Obstet Gynecol 2009; 200: 395.
Delić R, Stefanović M. Optimal laboratory panel for predicting preeclampsia. J Matern Fetal Neonatal Med 2010; 23: 96–102.
Kaypour F, Masomi Rad H, Ranjbar Novin N. The predictive value of serum uric acid, roll–over test and body mass index in preeclampsia. International J Gynecol Obstet 2006; 92: 133–4.
| Files | ||
| Issue | Vol 4, No 4 (December 2010) | |
| Section | Original Articles | |
| Keywords | ||
| Serum uric acid Iron TIBC Roll-over test Preeclampsia | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
